RGEN · Repligen Corp
United States · RS rating 80 · As of 2026-11-03
| Price | 178.27 USD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 43 / 84 / 68 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 57 / 52 / 46 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -11.5% |
| Sales growth Q/Q | +4.8% |
| Distance from 52-week high | +8.4% |
| Market cap (USD) | $6.4B |